Accelerating time to market of new drugs or vaccines, distributed supply chains, complex industry regulations, and huge development costs are some of the key challenges for Pharmaceutical & Life Science manufacturers. Quality controls slow everything down. New drugs addressing modern healthcare issues can take longer to be developed and delivered to patients .
In this challenging and stringent environment, technologies can help but their adoption creates other complex challenges when Pharma manufacturers cannot afford to stop production lines.
10 years
on average for a new drug to go from discovery to marketplace
Why choose Atos for Digital manufacturing in Pharma and Biotech
The Atos Life Sciences teams recognize that digital manufacturing is more than just about the right technology. It’s also about understanding the market challenges, knowing how to leverage on data to optimize business processes, ensuring a safe transition to new operating models and a smooth adoption by the manufacturing teams.

Serving the whole life science value chain
- Global Reach
- Central and Local Governance
- Total Orchestration Capabilities

Manufacturing in our DNA
- Digital Products Know-how
- Industry4.0 CoE
- MES & PLM Experts
- Prime Rankings by Analysts

Transformational approach
Consulting led approach from assessment and planning to roll out in multiple sites

Expertise and partners
- Partnerships in the most relevant technologies for Smarter Factories
- Atos Scaler Program
- Defense-in-depth IT/OT Security
- Cyber Analytics
- SecOps